Genesis Molecular AI
Genesis Molecular AI is building a software team to develop tools for drug discovery using machine learning, simulations, and computational chemistry. The company focuses on creating high-impact AI-driven platforms to generate and optimize drug molecules, advancing the field of pharmaceuticals.
Genesis Molecular AI is a biotechnology company delivering the industry’s most advanced molecular AI platform to unlock tough protein targets and accelerate drug discovery at scale. Its platform combines AI-driven analytics with molecular understanding to identify viable targets and design candidate medicines more efficiently. The solution is tailored for biotech and pharmaceutical teams seeking scalable, data-driven discovery workflows that shorten preclinical timelines. Genesis positions itself as a leader in AI-enabled drug discovery, helping researchers move faster from target to medicine.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genesis Molecular AI.
42% below the average for this role
Computational Chemist
Variational AI
Small Molecule Computational Scientist
Boltz
Senior Scientist, Computational Chemist
Bicycle Therapeutics
Computational Chemistry Scientist
Roche
Research Senior Scientist, Cheminformatics
Takeda Pharmaceutical Company Limited
Senior Scientist, Computational Chemistry
lifelancer